Cleo Ryals of the University of North Carolina at Chapel Hill also presented at the 2025 SABCS indicated there may be a connection between the use of GLP-1 agonists and reduced circulating tumor activity, suggesting that these medications may have benefits for patients with breast cancer beyond weight loss
Do not apply to irritated or damaged skin
Psychopharmacology & Therapeutics
FDA Regulations FDA compounding compliance under Sections 503A and 503B is a cornerstone of what we do for GLP-1 clients
Despite promising preliminary findings, these compounds are generally associated with a poor spatial and temporal control of the treatment as well as poor cancer selectivity, resulting in potential side effects and non-ideal drug doses
"In addiction medicine, a lot of treatments target just one thing, for example, a nicotine patch helps with smoking, but not alcohol, but there is no medication that works across addictive substances, let alone all of them," said senior author Ziyad Al-Aly, MD, a WashU Medicine clinical epidemiologist and Chief of the Research and Development Service at the VA Saint Louis Health Care System